
About Citro Pharma
Citro Pharma is a Healthcare company based in Guelph (Canada) by Kanti Mapara. Global manufacturer and exporter of pharmaceuticals, biopharmaceuticals, and vaccines. It operates on a B2B and Export model. Its Indian entity Citro Pharma Private Limited reported revenue of βΉ20.60 Cr. Citro Pharma offers products and services including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines. Its focus areas include Pharmaceuticals, Drugs, Oncology and Biosimilars and Biopharmaceuticals.
Company details
Citro Pharma, based in Canada, specializes in manufacturing and marketing a wide range of high-quality pharmaceutical and biopharmaceutical drugs, including oncology and biosimilars. They export products worldwide, partner with leading manufacturers, and focus on timely delivery and client satisfaction. The company operates in multiple countries, emphasizing affordable healthcare solutions through research and distribution.
- Headquarters Guelph, Canada
- Founders Kanti Mapara
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website citropharm.com
- Legal Name Citro Pharma Private Limited
- Date of Incorporation 14 Oct, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹20.60 Cr
FY 2025 · +3% YoY
- Indian entity net profit₹2.62 Cr
FY 2025 · 13% margin
- Indian entity EBITDA₹3.65 Cr
FY 2025 · 18% margin
Associated legal entities of Citro Pharma
Citro Pharma operates through Citro Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Citro Pharma Private Limited CIN U24230KA2016PTC097166 | Active | 14 Oct 2016 | Bangalore, Karnataka | ₹20.6 Cr | 3 | View details |
Products & Services of Citro Pharma
Citro Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines.
Solid form medications for various treatments and diseases.
Generic versions of injectable drugs for medical use.
Drugs targeting cancer therapy and related conditions.
Biological products similar to reference drugs.
Vaccines for disease prevention and immunization.
Products like human albumin for blood-related treatments.
Board of directors of Citro Pharma Private Limited (Citro Pharma)
Citro Pharma Private Limited is the primary company behind Citro Pharma. The board of Citro Pharma Private Limited currently have 3 directors; the longest-serving is Shaikh Mukhtar Ahmed, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shaikh Mukhtar Ahmed DIN 07637161 | Director | 14 Oct 2016 | 10 yrs 1 mo | Citro Pharma Private Limited |
| Mukhtar Ahmed DIN 07637162 | Director | 14 Oct 2016 | 10 yrs 1 mo | Citro Pharma Private Limited |
| Ashfaq Ahmed DIN 07634546 | Director | 14 Oct 2016 | 10 yrs 1 mo | Citro Pharma Private Limited |
People of Citro Pharma
1 people are tracked at Citro Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kanti Mapara | Founder | Leadership |
Complete people profiles for Citro Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Citro Pharma
Figures of Citro Pharma Private Limited, the primary company behind Citro Pharma, for FY 2025. Revenue was ₹20.60 Cr (+3% year on year). Net profit was ₹2.62 Cr (13% margin). EBITDA was ₹3.65 Cr (18% margin). Revenue has grown at a compounded annual rate of +6% over three years and +18% over five years.
- ₹20.60 CrRevenue · FY 2025 · +3% YoY
- ₹2.62 CrNet profit · 13% margin
- ₹3.65 CrEBITDA · 18% margin
- ₹1 LakhPaid-up capital
- +6%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Citro Pharma Private Limited are on its company page.
Detailed financial statements for Citro Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Citro Pharma
Citro Pharma is headquartered in Guelph, Canada. It is registered at Guelph, Ontario, Canada.
The primary company behind Citro Pharma, Citro Pharma Private Limited, reported revenue of βΉ20.60 Cr for FY 2025, up 3% year on year.
Citro Pharma, based in Canada, specializes in manufacturing and marketing a wide range of high-quality pharmaceutical and biopharmaceutical drugs, including oncology and biosimilars. They export products worldwide, partner with leading manufacturers, and focus on timely delivery and client satisfaction. The company operates in multiple countries, emphasizing affordable healthcare solutions through research and distribution.
Citro Pharma offers Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and 2 more products and services.
Citro Pharma operates through Citro Pharma Private Limited.
The legal entities of Citro Pharma currently have 3 directors, including Shaikh Mukhtar Ahmed, Mukhtar Ahmed, Ashfaq Ahmed.